MYC and neoplasm: Here, we report that pharmacological inhibition of c-Myc in osteosarcoma on the one hand promotes T cell trafficking into tumor beds by increasing the expression and secretion of T cell-recruiting chemokines and on the other hand facilitates crosstalk between antigen-presenting DCs and T cells through the CD40/CD40L costimulatory pathway.